CLINICAL_TRIALS
trial_result
· 2026-01-07
Clinical Trial Update: Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma [Phase 3]
Summary
Phase 3 trial completion evaluating Tezepelumab on airway structure and function in adults with uncontrolled moderate-to-severe asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: McMaster University | Conditions: Asthma | Phase 3 | Status: COMPLETED